Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Show other versions (1)

Lipoprotein(a) concentrations in plasma are associated with cardiovascular risk in the general population. Whether lipoprotein(a) concentrations or LPA genetic variants predict long-term mortality in patients with established coronary heart disease remains less clear.We obtained data from 3313 patie...

Full description

Bibliographic Details
Main Authors:	Zewinger, S, Kleber, M, Tragante, V, Holmes, M
Format:	Journal article
Language:	English
Published:	Elsevier 2017

Similar Items

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
by: Zewinger, S, et al.
Published: (2017)

Association of LPA variants with risk of coronary disease and the implications for Lipoprotein(a)-lowering therapies: a mendelian randomization analysis
by: Burgess, S, et al.
Published: (2018)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
by: Farrall, M, et al.
Published: (2010)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
by: Clarke, R, et al.
Published: (2009)

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
by: Erqou, S, et al.
Published: (2009)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
by: Hopewell, J, et al.
Published: (2011)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
by: Kyriakou, T, et al.
Published: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
by: Kyriakou, T, et al.
Published: (2014)

Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA).
by: Juan Zhao, et al.
Published: (2019-01-01)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
by: Clarke, R, et al.
Published: (2009)

<i>LPA</i> Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels
by: Andreja Rehberger Likozar, et al.
Published: (2021-12-01)

Genetic diversity and decoding the genetics of phytic acid by investigating the inheritance of lpa 2 allele in maize (Zea mays L.)
by: S. M. Indhu1, R. Ravikesavan1, N. Senthil2, T. Chitdeshwari3 and A. John Joel2
Published: (2024-03-01)

Regulation of T cell motility in vitro and in vivo by LPA and LPA2.
by: Sara A Knowlden, et al.
Published: (2014-01-01)

Apo B genetic variants that modulate postprandial lipoprotein metabolism
by: Talmud, P, et al.
Published: (1996)

MOLECULAR AND GENETIC MARKERS FOR CORONARY HEART DISEASE PROGNOSIS IN ELDERLY PATIENTS
by: N. A. Malygina, et al.
Published: (2009-08-01)

Lipoprotein(a) Genetic Variants Associated With Risk of Atherothrombotic Disease in 14,465 Participants From the Heart Protection Study
by: Hopewell, J, et al.
Published: (2010)

Association of FHL5 and LPA genetic polymorphisms with diabetes mellitus risk: a case-control study
by: Xuezhong Xu, et al.
Published: (2023-12-01)

Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer’s Disease Risk
by: Kimberley D. Bruce, et al.
Published: (2020-11-01)

Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma
by: Yap, L.F., et al.
Published: (2015)

The Emerging Role of LPA as an Oncometabolite
by: Theodoros Karalis, et al.
Published: (2024-04-01)

Phosphatidic Acid Stimulates Myoblast Proliferation through Interaction with LPA1 and LPA2 Receptors
by: Ana Gomez-Larrauri, et al.
Published: (2021-02-01)

Some molecular genetic markers of progressive atherosclerosis in patients with coronary heart disease
by: V. N. Maksimov, et al.
Published: (2022-04-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
by: Farrer, M, et al.
Published: (1993)

Association of the Lipoprotein Receptor SCARB1 Common Missense Variant rs4238001 with Incident Coronary Heart Disease.
by: Ani Manichaikul, et al.
Published: (2015-01-01)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
by: Hopewell, J, et al.
Published: (2012)

High genetic risk for depression as an independent risk factor for mortality in patients referred for coronary angiography
by: Robert M. Krämer, et al.
Published: (2023-06-01)

Genetic Analysis and Molecular Mapping of the Quantitative Trait Loci Governing Low Phytic Acid Content in a Novel LPA Rice Mutant, PLM11
by: Prem Chand Gyani, et al.
Published: (2020-12-01)

Approaches for establishing the function of regulatory genetic variants involved in disease.
by: Knight, J
Published: (2014)

Mainstream green : sustainable design by LPA
Published: (2005)

On the geometry of the multiplier space of ℓpA
by: Felder Christopher, et al.
Published: (2022-05-01)

DNA methylation profiling identifies a high effect genetic variant for lipoprotein(a) levels
by: Gregory T. Jones, et al.
Published: (2020-09-01)

Rare protein-truncating variants in APOB, lower low-density lipoprotein cholesterol, and protection against coronary heart disease
by: Peloso, G, et al.
Published: (2019)

Effects of LPA on the development of sheep in vitro fertilized embryos and attempt to establish sheep embryonic stem cells
by: Xue-min ZHANG, et al.
Published: (2023-04-01)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
by: Seedorf, U, et al.
Published: (2010)

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease
by: E. Sverre, et al.
Published: (2023-06-01)

Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate
by: Alexis C. Frazier-Wood, et al.
Published: (2014-08-01)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
by: K. I. Tebloev, et al.
Published: (2005-10-01)

Genetic Risk Score for Coronary Heart Disease: Review
by: Sergey Semaev, et al.
Published: (2020-11-01)

Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes
by: Lotta, L, et al.
Published: (2018)

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
by: Danesh, J, et al.
Published: (2000)